Cargando…

Behavior of Mebendazole during NF/RO Adsorption and Photolysis

The idea of using drugs from the benzimidazole group as potential antitumor agents is becoming increasingly popular and widespread in research. However, their use as antiparasitics and in cancer treatment will increase their already recorded occurrence in the aquatic environment. In this study, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Babić, Bruna, Andrić, Darko, Farkaš, Anamarija, Vuk, Dragana, Ašperger, Danijela, Dolar, Davor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503556/
https://www.ncbi.nlm.nih.gov/pubmed/36135907
http://dx.doi.org/10.3390/membranes12090888
_version_ 1784795992963416064
author Babić, Bruna
Andrić, Darko
Farkaš, Anamarija
Vuk, Dragana
Ašperger, Danijela
Dolar, Davor
author_facet Babić, Bruna
Andrić, Darko
Farkaš, Anamarija
Vuk, Dragana
Ašperger, Danijela
Dolar, Davor
author_sort Babić, Bruna
collection PubMed
description The idea of using drugs from the benzimidazole group as potential antitumor agents is becoming increasingly popular and widespread in research. However, their use as antiparasitics and in cancer treatment will increase their already recorded occurrence in the aquatic environment. In this study, the removal of the anthelmintic mebendazole from aqueous solution was investigated using nanofiltration and reverse osmosis membranes, adsorption on granular activated carbon (GAC), and photolytic degradation. The dense NF90 and reverse osmosis XLE membranes showed almost complete removal (>97.7%), while the NF270 membrane showed a large dependence of removal on initial concentration from 41.9% to 96.6%. Adsorption in the column resulted in complete removal of mebendazole at the highest GAC height used (40 cm) from the solution with the lowest concentration (1 mg/L). Photolytic degradation by artificial light for 2 and 12 h resulted in photodegradation of mebendazole in the range of 23.5–61.4%, forming a new degradation or transformation compound with an m/z ratio of 311. Mebendazole is a photosensitive drug whose photodegradation follows first-order kinetics and depends on the drug concentration. Toxicity was studied with Vibrio fischeri before and after photolysis, and showed a decrease in inhibition after 12 h.
format Online
Article
Text
id pubmed-9503556
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95035562022-09-24 Behavior of Mebendazole during NF/RO Adsorption and Photolysis Babić, Bruna Andrić, Darko Farkaš, Anamarija Vuk, Dragana Ašperger, Danijela Dolar, Davor Membranes (Basel) Article The idea of using drugs from the benzimidazole group as potential antitumor agents is becoming increasingly popular and widespread in research. However, their use as antiparasitics and in cancer treatment will increase their already recorded occurrence in the aquatic environment. In this study, the removal of the anthelmintic mebendazole from aqueous solution was investigated using nanofiltration and reverse osmosis membranes, adsorption on granular activated carbon (GAC), and photolytic degradation. The dense NF90 and reverse osmosis XLE membranes showed almost complete removal (>97.7%), while the NF270 membrane showed a large dependence of removal on initial concentration from 41.9% to 96.6%. Adsorption in the column resulted in complete removal of mebendazole at the highest GAC height used (40 cm) from the solution with the lowest concentration (1 mg/L). Photolytic degradation by artificial light for 2 and 12 h resulted in photodegradation of mebendazole in the range of 23.5–61.4%, forming a new degradation or transformation compound with an m/z ratio of 311. Mebendazole is a photosensitive drug whose photodegradation follows first-order kinetics and depends on the drug concentration. Toxicity was studied with Vibrio fischeri before and after photolysis, and showed a decrease in inhibition after 12 h. MDPI 2022-09-15 /pmc/articles/PMC9503556/ /pubmed/36135907 http://dx.doi.org/10.3390/membranes12090888 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Babić, Bruna
Andrić, Darko
Farkaš, Anamarija
Vuk, Dragana
Ašperger, Danijela
Dolar, Davor
Behavior of Mebendazole during NF/RO Adsorption and Photolysis
title Behavior of Mebendazole during NF/RO Adsorption and Photolysis
title_full Behavior of Mebendazole during NF/RO Adsorption and Photolysis
title_fullStr Behavior of Mebendazole during NF/RO Adsorption and Photolysis
title_full_unstemmed Behavior of Mebendazole during NF/RO Adsorption and Photolysis
title_short Behavior of Mebendazole during NF/RO Adsorption and Photolysis
title_sort behavior of mebendazole during nf/ro adsorption and photolysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503556/
https://www.ncbi.nlm.nih.gov/pubmed/36135907
http://dx.doi.org/10.3390/membranes12090888
work_keys_str_mv AT babicbruna behaviorofmebendazoleduringnfroadsorptionandphotolysis
AT andricdarko behaviorofmebendazoleduringnfroadsorptionandphotolysis
AT farkasanamarija behaviorofmebendazoleduringnfroadsorptionandphotolysis
AT vukdragana behaviorofmebendazoleduringnfroadsorptionandphotolysis
AT aspergerdanijela behaviorofmebendazoleduringnfroadsorptionandphotolysis
AT dolardavor behaviorofmebendazoleduringnfroadsorptionandphotolysis